This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Antibioticos, S.a.u., Antibiotics, S.a., Sntibioticos, S. a.. Active years: 2000-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2003
Title: Innovations of Jose Luis Garcia Lopez
Introduction
Jose Luis Garcia Lopez is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of enzymatic processes, particularly in the preparation of cephalosporanic acids. With a total of 3 patents, his work has advanced the understanding and application of enzymes in pharmaceutical processes.
Latest Patents
His latest patents include an enzymatic process for the preparation of cephalosporanic 7β-(4-Carboxybutanamide) acid using the modified enzyme D-aminoacid oxidase of Trigonopsis variabilis produced in Escherichia coli. This innovative process involves several steps, including isolating the DNA corresponding to the gene coding for the enzyme, removing introns, and transforming host cells to cultivate the enzyme. Another patent focuses on the production of the enzyme D-amino acid oxidase of Rhodotorula gracilis in host cells, detailing a method for isolating complementary DNA and cultivating transformed host cells.
Career Highlights
Throughout his career, Jose Luis Garcia Lopez has worked with prominent companies such as Antibiotics, S.A. and Antibioticos, S.A.U. His expertise in enzymatic processes has made him a valuable asset in the pharmaceutical industry.
Collaborations
He has collaborated with notable coworkers, including Estrella Cortes Rubio and Bruno Diez Garcia. Their combined efforts have contributed to the advancement of enzymatic research and applications.
Conclusion
Jose Luis Garcia Lopez's innovative work in enzymatic processes has led to significant advancements in the pharmaceutical field. His contributions continue to influence the development of new therapeutic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile